Market: Copenhagen Symbol: CHR ISIN: DK0060227585
Chr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and HMOs for a variety of foods, beverages, dietary supplements, animal feed and crop protection.
Share Data 05/10/2022
Currency DKK
Previous Close 387.10
52 Weeks % -25.65
Volume 215,706
Number of Shares 131,852,496
Market Cap (bil.) 51.0
Previous Close Currency 52 Weeks % Volume Number of Shares Market Cap (bil.)
387.10 DKK -25.65 215,706 131,852,496 51.0

Key figures, EUR million

         
Income statement (cont. operations) 2020/21 2019/20 2018/19 2017/18 2016/17
Revenue 1,077.4 970.0 937.4 1,097.4 1,062.5
Gross profit 613.4 584.0 576.9 600.6 578.1
EBITDA before special items 399.3 400.6 372.3 384.0 368.1
EBIT before special items 298.1 326.9 314.7 320.2 307.1
EBIT 276.2 313.0 312.4 320.2 305.7
Net financial items (22.5) (13.5) (16.1) (24.1) (14.8)
Profit from continuing operations 198.7 231.6 229.2 228.2 224.0
Profit from discontinued operations 646.5 13.4 21.0 - -
Profit for the year 845.2 245.0 250.2 228.2 224.0
           
Cash flow (Group) 2020/21 2019/20 2018/19 2017/18 2016/17
Cash flow from operating activities 310.8 364.6 298.6 302.4 283.7
Cash flow from investing activities 284.5 (807.5) (81.6) (107.0) (176.5)
Free cash flow 595.3 (442.9) 217.0 195.4 107.2
Free cash flow before acquisitions and special items 183.9 244.5 229.1 195.9 187.8
Free cash flow before acquisitions and special items, cont. operations 196.4 224.9 220.2 - -
           
Balance sheet (Group) 2020/21 2019/20 2018/19 2017/18 2016/17
Total assets ¹⁾ 3,114.2 2,853.6 2,057.8 1,861.1 1,802.1
Invested capital ¹⁾ 2,793.1 2,487.6 1,745.3 1,631.5 1,581.1
Net working capital ¹⁾ 190.1 208.1 220.6 189.1 174.8
Equity 1,626.1 893.0 797.2 771.6 768.5
Net interest-bearing debt 898.2 1,345.0 734.4 658.7 628.4
           
Key ratios 2020/21 2019/20 2018/19 2017/18 2016/17
           
Continuing operations          
Organic growth, % 7 6 8 9 10
Gross margin, % 56.9 60.2 61.5 54.7 54.4
EBITDA margin before special items, % 37.1 41.3 39.7 35.0 34.6
EBIT margin before special items, % 27.7 33.7 33.6 29.2 28.9
EBIT margin, % 25.6 32.3 33.3 29.2 28.8
ROIC excl. goodwill, % 24.8 33.6 39.2 38.0 40.1
ROIC, % 11.6 16.8 20.3 19.9 20.3
R&D, % 8.5 8.0 8.1 7.3 7.0
Capital expenditure, % 14.5 12.2 12.6 9.8 10.0
Earnings per share diluted, EUR 1.51 1.76 1.74 - -
Average number of employees (FTEs) 3,398 2,932 2,768 3,151 2,940
           
Group          
Earnings per share diluted, EUR 6.41 1.86 1.90 1.73 1.68
Net debt to EBITDA before special items 2.3x 3.1x 1.8x 1.7x 1.7x

Following the classification of the Natural Colors business as discontinued operations in 2019/20, the business is presented separately on an aggregated level in the income statement, balance sheet and cash flow statement. In accordance with IFRS, the income statement and the cash flow statement have both been restated in previous periods, while the balance sheet has not been restated in previous periods. The comparative figures for 2016/17 - 2017/18 have not been restated and are not directly comparable.

Numbers are not restated and therefore not directly comparable

¹⁾ The Natural Colors business was divested as of March 31, 2021. For the financial years 2016/17-2019/20, total assets, invested capital and net working capital include assets and liabilities related to the Natural Colors business.